风湿消息
EULAR 2026 | “风”起东方——北京大学人民医院篇
点击蓝字 关注我们
2026年6月3日至6日，全球风湿病学领域的目光将聚焦英国伦敦——欧洲抗风湿病联盟（EULAR）年度大会即将在此启幕！这场被誉为“风湿病学领域灯塔”的盛会，不仅将汇聚全球顶尖专家、临床医生及患者组织，更将揭晓多项科研突破与创新实践。
2026 年 EULAR 大会提交的逾 5700 篇摘要！大会委员会已遴选出 1700 余篇摘要，纳入本次伦敦大会的学术日程。
经过平台不完全统计，本次EULAR 2026共收入中国学者150+篇研究成果，其中包括35+篇oral。
数据由AI整理具体日程抓取获得，如果有遗漏，请留言哦！
具体中国学者oral以及poster列表可见下表：
EULAR2026_中国学者研究成果汇总表0514.xlsx
自免视界、罕见病视界作为EULAR多年的支持媒体，为便于广大学者深入了解此次会议的精彩内容，特此整理了国内医院/研究所的研究成果展示合集。本文梳理了北京大学人民医院（第一作者/通讯单位）的相关摘要，一起先睹为快吧！
•
✦
✦
•
摘要号：OP0284
讲题：
Single‑Cell Transcriptomic and Proteomic Profiling Highlights the Role of GZMK+ CD8+ T Cells in Severe Vascular Behçet's Syndrome
讲者：
Jiachen Li
Rome:
Connaught Room 1 & 2
Date:
Friday, 5 June, 08:45 - 08:55 BST
摘要号：OP0355
讲题：
Efficacy and safety of tetrandrine in patients with rheumatoid arthritis (TRAL): a multicenter randomized, double-blind, placebo-controlled trial
讲者：
Miao Shao
Rome:
George V Room 1
Date:
Friday, 5 June, 08:55 - 09:05 BST
摘要号：暂无
讲题：
Low-dose IL-2: a Promising Topical Treatment for Sjögren’s Disease-Related Dry Eye Disease
讲者：
Bo Huang
✦
✦
•
摘要号：POS0688
Presentation Type:
Poster View
讲题：
Obinutuzumab β (MIL62), a Novel Glycoengineered Type II Anti-CD20 Antibody, for Active Lupus Nephritis: 104-Week Results of a Phase 1b/2 Randomized, Double-Blind, Placebo-Controlled Trial
讲者：
Yuhui Li
Rome:
Poster View
Date:
Thursday, 4 June, 18:30 - 18:40 BST摘要号：POS0713
Presentation Type:
Poster View
讲题：
ORELABRUTINIB, A HIGHLY SELECTIVE INHIBITOR OF BRUTON'S TYROSINE KINASE(BTK), FOR THE TREATMENT OF SYSTEMIC LUPUS ERYTHEMATOSUS(SLE): RESULTS OF A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED, PHASE IIB STUDY
讲者：
Zhanguo Li
Rome:
Poster View
Date:
Thursday, 4 June, 16:40 - 16:50 BST摘要号：POS1065
Presentation Type:
Poster View
讲题：
Unsupervised Clustering of Clinical and Laboratory Features of Systemic Lupus Erythematosus: Insights from a Multicenter Cohort
讲者：
Yuke Hou
Rome:
Poster View
Date:
Friday, 5 June, 16:00 - 16:00 BSTPresentation Type:
Poster View
讲题：
Therapeutic Role of Interleukin-2 in Lupus-Associated Diffuse Alveolar Hemorrhage via Modulating T cell Subsets
讲者：
Xingyue Zeng
Rome:
Poster View
Date:
Saturday, 6 June, 10:15 - 10:15 BSTPresentation Type:
Poster View
讲题：
levated serum anti-CD27 antibodies are associated with disease activity and treatment response in patients with rheumatoid arthritis
讲者：
Jing He
Rome:
Poster View
Date:
Saturday, 6 June, 10:15 - 10:15 BSTPresentation Type:
Poster Tour
讲题：
CNS diseases cerebrospinal fluid single-cell atlas reveals immune characteristics of neuropsychiatric systemic lupus erythematosus
讲者：
Haihong Yao
Rome:
Poster Tour III
Date:
Thursday, 4 June, 09:36 - 09:42 BSTPresentation Type:
Poster View
讲题：
Increased Circulating Granzyme K+ CD8+ T Cells Correlate with Disease Activity and Therapeutic Response to TNF Inhibitors in Rheumatoid Arthritis
讲者：
Yuetong Qi
Rome:
Poster View
Date:
Saturday, 6 June, 10:15 - 10:15 BSTPresentation Type:
Poster View
讲题：
Obinutuzumab β (MIL62), a Novel Glycoengineered Type II Anti-CD20 Antibody,
for Active Lupus Nephritis: 104-Week Results of a Phase 1b/2 Randomized,Double-Blind, Placebo-Controlled Trial
讲者：
Zhanguo Li
Rome:
Poster View
Date:
Thursday, 4 June, 18:30-18:40 BST•
✦
✦
•
完整日程下载地址：EULAR 2026_Programme Export.pdf
具体信息来源EULAR官网：
EULAR 2026 | Scientific Programme
https://congress.eular.org/programme#nav_tabs_content_1770974497227_1079
本篇院校数据由北京大学人民医院科室进行审核
版权所有 © 北京大学人民医院风湿免疫研究所
技术支持：优河马